https://www.nzteco.co.nz/product/zkteco-atlas-bio-series/
ZKTeco Atlas Bio Series: Biometric Door Access Control
ZKTeco Atlas Bio Series offers state-of-the-art biometric door access control panels for 1, 2, and 4 doors with built-in web application.
bio seriesdoor accesszktecoatlasbiometric
https://biobriefs.com/autonomous-funding-latus-bio-series
Autonomous funding: Latus Bio series A for AAV capsid platform | BioBriefs
May 5, 2026 - Latus Bio closed a $97 million Series A to advance a therapeutics pipeline built around novel AAV capsid variants, funding operations through milestones tied...
bio seriesautonomousfunding
https://zkteco.in/atlas_series/atlas-bio-series
Atlas Bio Series, multi door controller
Atlas Bio Series | Access Control Panel
bio seriesmulti dooratlascontroller
https://www.vcaonline.com/news/2026050402/latus-bio-announces-97-million-series-a-financing-to-expand-the-reach-of-gene-therapy-to-larger-populations/
Latus Bio Announces $97 Million Series A Financing to Expand the Reach of Gene Therapy to Larger...
Latus Bio, Inc. (Latus), a biotechnology company engineering scalable gene therapies for broader patient populations, today announced the closing of a $97...
https://nivina-bio.com.vn/en/optics-nikon-biological-microscope-eng/nikon-advanced-modulation-contrast-objective-series-2/
Nikon Advanced Modulation Contrast Objective Series - Bio Nivina
Nikon Advanced Modulation Contrast -Dedicated objectives for advanced modulation contrast.
nikonadvancedmodulationcontrastobjective
https://www.biotihealth.com/
Spirulina Series, Standard Extract, Mushroom Serie Suppliers - Hangzhou Muhua Bio-Tech Co., Ltd
Spirulina Series Factory,Standard Extract Suppliers,Manufacturers,China High quality Mushroom Serie Company,Sales Standard Extract Manufacturers.
https://www.prnewswire.com/news-releases/solarea-bio-announces-series-a-financing-led-by-s2g-ventures-and-bold-capital-partners-301154473.html
Solarea Bio Announces Series A Financing Led by S2G Ventures and Bold Capital Partners
/PRNewswire/ -- Solarea Bio, a biotech company based in Cambridge, MA developing microbial-based solutions to aid human health, announced today it has raised...